BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28738839)

  • 1. Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.
    Harnois-Leblanc S; Trottier A; Leblanc S; Battista MC; Geller DH; Baillargeon JP
    Reprod Biol Endocrinol; 2017 Jul; 15(1):56. PubMed ID: 28738839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.
    Trottier A; Battista MC; Geller DH; Moreau B; Carpentier AC; Simoneau-Roy J; Baillargeon JP
    Fertil Steril; 2012 Dec; 98(6):1627-34. PubMed ID: 22985947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
    Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
    Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
    Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
    Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.
    Harnois-Leblanc S; Hernandez MI; Codner E; Cassorla F; Oberfield SE; Leibel NI; Mathew RP; Ten S; Magoffin DA; Lane CJ; Goran MI; Azziz R; Baillargeon JP; Geller DH
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e912-e923. PubMed ID: 34752621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.
    Torchen LC; Fogel NR; Brickman WJ; Paparodis R; Dunaif A
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3855-62. PubMed ID: 25029420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women.
    Maliqueo M; Galgani JE; Pérez-Bravo F; Echiburú B; de Guevara AL; Crisosto N; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):56-61. PubMed ID: 22277163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.
    Chiavaroli V; Liberati M; D'Antonio F; Masuccio F; Capanna R; Verrotti A; Chiarelli F; Mohn A
    Eur J Endocrinol; 2010 Jul; 163(1):55-62. PubMed ID: 20356934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study.
    Legro RS; Kunselman AR; Stetter CM; Gnatuk CL; Estes SJ; Brindle E; Vesper HW; Botelho JC; Lee PA; Dodson WC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):122-131. PubMed ID: 27778640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.
    Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):667-72. PubMed ID: 11894979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitivity and lipid profiles in girls with central precocious puberty before and during gonadal suppression.
    Sørensen K; Mouritsen A; Mogensen SS; Aksglaede L; Juul A
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3736-44. PubMed ID: 20484471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
    Carbunaru G; Prasad P; Scoccia B; Shea P; Hopwood N; Ziai F; Chang YT; Myers SE; Mason JI; Pang S
    J Clin Endocrinol Metab; 2004 Feb; 89(2):783-94. PubMed ID: 14764797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys.
    Ayonrinde OT; Adams LA; Doherty DA; Mori TA; Beilin LJ; Oddy WH; Hickey M; Sloboda DM; Olynyk JK; Hart R
    J Gastroenterol Hepatol; 2016 May; 31(5):980-7. PubMed ID: 26589977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10-20-year longitudinal cohort study in southern Thailand.
    Satitpatanapan P; Jaruratanasirikul S; Sriplung H
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):933-940. PubMed ID: 32623380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.